{"url":"https://lda.senate.gov/api/v1/filings/9e743fa9-e27c-4e57-9b10-69e479863dc2/","filing_uuid":"9e743fa9-e27c-4e57-9b10-69e479863dc2","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2014,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/9e743fa9-e27c-4e57-9b10-69e479863dc2/print/","filing_document_content_type":"text/html","income":null,"expenses":"510000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Timothy J. McBride, VP Global Government Affairs","dt_posted":"2014-07-21T08:01:06.750000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"701 8th Street","registrant_address_2":"Suite 620","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":319778,"url":"https://lda.senate.gov/api/v1/registrants/319778/","house_registrant_id":39509,"name":"COVIDIEN LP","description":"Medical Products Manufacturer","address_1":"701 8th Street","address_2":"Suite 620","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WHITNEY GARDINER","contact_telephone":"+1 202-442-3647","dt_updated":"2022-04-06T16:08:25.664832-04:00"},"client":{"id":186509,"url":"https://lda.senate.gov/api/v1/clients/186509/","client_id":12,"name":"COVIDIEN LP","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-06-04"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to free trade agreements in European Union and Asia.","foreign_entity_issues":"As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.","lobbyists":[{"lobbyist":{"id":51224,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MCBRIDE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":35735,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"GARDINER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41831,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"CHRISTOPHER","last_name":"KALAVRITINOS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).S.2360/ H.R.4679 The Stop Corporate Inversions Act of 2014  (Provisions related to management and control); H.R.4985 - Stop Corporate Expatriation and Invest in America's Infrastructure Act of 2014 (Provisions related to management and control)","foreign_entity_issues":"As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.","lobbyists":[{"lobbyist":{"id":35735,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"GARDINER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41831,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"CHRISTOPHER","last_name":"KALAVRITINOS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":51224,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MCBRIDE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"ECN","general_issue_code_display":"Economics/Economic Development","description":"H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)","foreign_entity_issues":"As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.","lobbyists":[{"lobbyist":{"id":35735,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"GARDINER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues relating to implementation of provisions of the Food and Drugs Administration Safety and Innovation Act related to device review; Issues related to sequestration of the FDA medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.Issues related to SGR legislation and the provision to create a CMS pilot program to encourage more home-based remote monitoring.  Issues related to medicare coverage of early lung cancer screening.","foreign_entity_issues":"As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.","lobbyists":[{"lobbyist":{"id":35735,"prefix":null,"prefix_display":null,"first_name":"WHITNEY","nickname":null,"middle_name":null,"last_name":"GARDINER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41831,"prefix":"mr","prefix_display":"MR.","first_name":"JOHN","nickname":null,"middle_name":"CHRISTOPHER","last_name":"KALAVRITINOS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false},{"lobbyist":{"id":51224,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"MCBRIDE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}